Navigation Links
2nd Generation Antidepressants Prove Effective
Date:11/18/2008

New guideline from American College of Physicians calls them equally good

TUESDAY, Nov. 18 (HealthDay News) -- Second generation antidepressants are all equally effective, according to a new clinical practice guideline released by the American College of Physicians.

The guideline authors reviewed more than 200 published studies about the benefits and risks of the following second generation drugs: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazadone and venlafaxine.

"The studies we analyzed show that second generation drugs have different adverse effects but are equally effective for treating depression," lead author Dr. Amir Qaseem, senior medical associate in ACP's Clinical Programs and Quality of Care Department, said in a group news release.

"ACP recommends that physicians make treatment decisions based on side effects, cost, and patient preferences, and make necessary changes in therapy if the response is not sufficient after six to eight weeks. Doctors should also assess patient status and adverse effects on a regular basis starting within one to two weeks of starting the treatment."

The guideline also recommends that doctors continue treatment for four to nine months after a satisfactory response to an antidepressant in patients with a first episode of major depression. A longer course of treatment may help prevent relapse or recurrence in patients who've had two or more episodes of depression.

The guideline was published Nov. 18 in the journal Annals of Internal Medicine.

Depression, which will affect about 16 percent of American adults at some point in their lives, can be triggered by stressful situations such as the loss of a job or death of a loved one. Depression treatment options include drugs, psychotherapy, and cognitive behavioral therapy.

In drug therapy, second generation antidepressants are often used, because they're effective and have fewer side effects than older antidepressants.

More information

The U.S. National Institute of Mental Health has more about depression.



-- Robert Preidt



SOURCE: American College of Physicians, news release, Nov. 18, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers find stem cells from monkey teeth can stimulate growth and generation of brain cells
2. Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008.
3. Kevin P. Miller's Film "Generation RX" Reveals Widespread Ethical Conflicts, Risks of Psychiatric Drugs to Children
4. United Spinal Association Launches VetsFirst.org Help Center: The Next Generation Veterans Service Organization
5. Ellex Announces Six-Month Results on Retina Regeneration Therapy
6. New advancements in the use of adult, embryonic stem cells for tissue regeneration
7. Long-Term Results of VisionCares Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
8. Veterans Day: New PTSD Brochure - Transmission of Trauma Can Span Generations
9. DecisionView Unveils the Next Generation of Clinical Trial Software: StudyOptimizer 4.0
10. GBH Communications, Inc. Offers Next Generation of LifeSize High Definition Video Communications and Telepresence Products
11. 60s generation is heading for conventional old age
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
2nd Generation Antidepressants Prove Effective
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that really ... cream can be incorporated into the post-surgical treatment plans of a variety of other ... dermaka cream is very effective for bruising and causes a rapid resolution of bruising ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology: